Prognosis of HIV-associated non-Hodgkin lymphoma in patients starting combination antiretroviral therapy

Bohlius, Julia; Schmidlin, Kurt; Costagliola, Dominique; Fätkenheuer, Gerd; May, Margaret; Caro Murillo, Ana Maria; Mocroft, Amanda; Bonnet, Fabrice; Clifford, Gary; Touloumi, Giota; Miro, Jose M; Chene, Genevieve; Lundgren, Jens; Egger, Matthias (2009). Prognosis of HIV-associated non-Hodgkin lymphoma in patients starting combination antiretroviral therapy. AIDS, 23(15), pp. 2029-37. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1097/QAD.0b013e32832e531c

[img] Text
COHEREStudyGroup AIDS 2009.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (197kB) | Request a copy

OBJECTIVE: We examined survival and prognostic factors of patients who developed HIV-associated non-Hodgkin lymphoma (NHL) in the era of combination antiretroviral therapy (cART). DESIGN AND SETTING: Multicohort collaboration of 33 European cohorts. METHODS: We included all cART-naive patients enrolled in cohorts participating in the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) who were aged 16 years or older, started cART at some point after 1 January 1998 and developed NHL after 1 January 1998. Patients had to have a CD4 cell count after 1 January 1998 and one at diagnosis of the NHL. Survival and prognostic factors were estimated using Weibull models, with random effects accounting for heterogeneity between cohorts. RESULTS: Of 67 659 patients who were followed up during 304 940 person-years, 1176 patients were diagnosed with NHL. Eight hundred and forty-seven patients (72%) from 22 cohorts met inclusion criteria. Survival at 1 year was 66% [95% confidence interval (CI) 63-70%] for systemic NHL (n = 763) and 54% (95% CI: 43-65%) for primary brain lymphoma (n = 84). Risk factors for death included low nadir CD4 cell counts and a history of injection drug use. Patients developing NHL on cART had an increased risk of death compared with patients who were cART naive at diagnosis. CONCLUSION: In the era of cART two-thirds of patients diagnosed with HIV-related systemic NHL survive for longer than 1 year after diagnosis. Survival is poorer in patients diagnosed with primary brain lymphoma. More advanced immunodeficiency is the dominant prognostic factor for mortality in patients with HIV-related NHL.

Item Type:

Journal Article (Original Article)


04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Social and Preventive Medicine (ISPM)

UniBE Contributor:

Bohlius, Julia; Schmidlin, Kurt and Egger, Matthias






Lippincott Williams & Wilkins




Factscience Import

Date Deposited:

04 Oct 2013 15:09

Last Modified:

23 Jun 2015 15:12

Publisher DOI:


PubMed ID:


Web of Science ID:




URI: (FactScience: 191376)

Actions (login required)

Edit item Edit item
Provide Feedback